AffyImmune Therapeutics (“Affy”), a clinical stage biotechnology company focused on creating technologies that expand the utility and improve the safety of cell-based immunotherapy for cancer, is seeking a Director of CMC to oversee and recommend improvements to the company’s manufacturing processes. Working alongside our Chief Operating Officer, you will join a [...]
AffyImmune Therapeutics (“Affy”), a clinical stage biotechnology company focused on developing technologies that expand the utility and improve the safety and efficacy of cell-based immunotherapy for cancer, is seeking a highly motivated Scientist (Biochemistry) to help advance the use of CAR T therapy for solid tumors. As a Scientist, you will [...]
NATICK, Mass. (AUGUST 19, 2021) – AffyImmune Therapeutics, Inc., a clinical stage biotechnology company finding safe, effective ways to use CAR T cells against solid cancers, announced today that scientific co-founder Moonsoo Jin will present twice at Hanson Wade’s 6th CAR-TCR Summit being held virtually August 30 – September 2. [...]